Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Xu, Lihua ^a   Ding, Xiangmin ^b   Tan, Huo ^a   Qian, Jianjun ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

B7 H3 expression; MMP 2; Pancreatic cancer; Prognosis

Indexed keywords

B7 H3 PROTEIN; GELATINASE A; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PANCREAS CANCER; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION;

EID: 84881500229     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-81     Document Type: Article

References (24)

1. Laheru D, Jaffee EM. Immunotherapy for pancreatic cancer - science driving clinical progress. Nat Rev Cancer 2005, 5:459-467.
2. Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P, Li GL, Wu LY, He J. Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res 2012, 24:171-180. 10.1007/s11670-012-0171-2, 3555287, 23359321.
3. Labianca R, Merelli B, Mosconi S. Treatment of advanced pancreatic cancer. Ann Oncol 2012, 23(Suppl 10):x139-x140. 10.1093/annonc/mds355, 22987950.
4. Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology 2010, 139(1080):1076-1080. e1071-1072, 3149791, 20727885.
5. Gonda TA, Lucas A, Saif MW. Screening and detection of pancreatic cancer. Highlights from the " 2011 ASCO Annual Meeting" Chicago, IL, USA; June 3-7, 2011. JOP 2011, 12:322-324.
6. Wang J, Liu L, Xie L, Xiang G, Zhou Y. Induction of differentiation-specific miRNAs in TPA-induced myeloid leukemia cells through MEK/ERK activation. Int J Mol Med 2013, 31:59-66.
7. Xu YH, Zhang GB, Wang JM, Hu HC. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis. Saudi Med J 2010, 31:980-986.
8. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y. Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 2009, 101:1709-1716. 10.1038/sj.bjc.6605375, 2778545, 19844235.
9. Zhang G, Xu Y, Lu X, Huang H, Zhou Y, Lu B, Zhang X. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 2009, 66:245-249. 10.1016/j.lungcan.2009.01.017, 19269710.
10. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 2011, 102:1019-1024. 10.1111/j.1349-7006.2011.01877.x, 21251161.
11. Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF, Zhao JM, Zhang GB, Zhang XG. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 2006, 12:457-459.
12. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer 2012, 130:2282-2290. 10.1002/ijc.26238, 21671471.
13. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67. 10.1016/j.cell.2010.03.015, 2862057, 20371345.
14. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000, 36:1621-1630. 10.1016/S0959-8049(00)00156-8, 10959048.
15. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174. 10.1038/nrc745, 11990853.
16. Kjellman M, Enberg U, Hoog A, Larsson C, Holst M, Farnebo LO, Sato H, Backdahl M. Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas. World J Surg 1999, 23:237-242. 10.1007/PL00013183, 9933692.
17. Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 2000, 24:334-340. 10.1007/s002689910053, 10658069.
18. Ferretti S, Patriarca S, Carbone A, Zanetti R. [TNM classification of malignant tumours, VII edition 2009. Changes and practical effects on cancer epidemiology]. Epidemiol Prev 2009, 2010(34):125-128.
19. Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, Buchler MW, Giese NA, Friess H. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 2005, 24:4421-4432. 10.1038/sj.onc.1208642, 15856026.
20. Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, Zhang YQ, Li JQ. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2006, 132:547-555. 10.1007/s00432-006-0097-5, 16763805.
21. Li H, Wang C, Guo G, Gao C, Wu Y, Chen Y. The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochem 2012, 114:733-743. 10.1016/j.acthis.2011.12.010, 22305414.
22. Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG, Zhao H. B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med 2013, 31:283-291.
23. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996, 271:1734-1736. 10.1126/science.271.5256.1734, 8596936.
24. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006, 53:143-151. 10.1016/j.lungcan.2006.05.012, 16782226.